Share this article
Share this article
BALTIMORE, Dec. 14, 2020 /PRNewswire/ Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities,
OPTAVIA®, announced that Non- Executive Chairman of the Board, Michael MacDonald, has stepped down from the role. At its regularly scheduled board meeting, the Board of Directors unanimously appointed Medifast s Chief Executive Officer, Dan Chard, to the role of Executive Chairman effective immediately. Chard will also retain his role as Chief Executive Officer.
Michael MacDonald joined Medifast as member of the Board of Directors in 1998, and was named Executive Chairman in 2011. He was promoted to Executive Chairman and Chief Executive Officer in 2012 and launched the
Share this article
Share this article
BALTIMORE, Dec. 10, 2020 /PRNewswire/ Medifast, Inc. (NYSE: MED), the company behind one of the fastest-growing health and wellness communities,
OPTAVIA®, announced today that its Board of Directors has declared a $1.13 quarterly cash dividend to its stockholders. The quarterly cash dividend of $1.13 per share is payable on February 5, 2021 to stockholders of record as of the close of business on December 22, 2020.
This will be the 20th consecutive quarterly dividend paid to stockholders, and the company has paid out to stockholders $139 million in cash dividends since December 2015. Medifast expects to maintain a program of paying dividends on a quarterly basis. The amount and declaration of future dividends remains subject to the discretion of the company s Board of Directors (the Board ), who will evaluate the company s dividend program from time to time based on factors that it deems relevant.